Susquehanna International Group
IDNA icon

Susquehanna International Group’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Susquehanna International Group’s Portfolio IDNA Stock Details IDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,655
Closed -$331K – 13581
2025
Q4 		$331K Buy
+12,655
New +$326K ﹤0.01% 9723
2025
Q3 		– Sell
-41,505
Closed -$851K – 13076
2025
Q2 		$851K Buy
41,505
+1,804
+5% +$36.3K ﹤0.01% 7852
2025
Q1 		$813K Sell
39,701
-56,664
-59% -$1.26M ﹤0.01% 7781
2024
Q4 		$2.18M Buy
96,365
+62,797
+187% +$1.51M ﹤0.01% 5110
2024
Q3 		$826K Buy
33,568
+12,038
+56% +$293K ﹤0.01% 7268
2024
Q2 		$498K Buy
+21,530
New +$504K ﹤0.01% 8278
2024
Q1 		– Sell
-25,752
Closed -$593K – 12684
2023
Q4 		$593K Sell
25,752
-65,467
-72% -$1.32M ﹤0.01% 8244
2023
Q3 		$1.86M Buy
91,219
+15,432
+20% +$346K ﹤0.01% 5282
2023
Q2 		$1.77M Buy
75,787
+25,133
+50% +$603K ﹤0.01% 5399
2023
Q1 		$1.18M Buy
50,654
+30,815
+155% +$771K ﹤0.01% 6383
2022
Q4 		$499K Buy
+19,839
New +$533K ﹤0.01% 7878
2022
Q3 		– Sell
-62,142
Closed -$1.8M – 13609
2022
Q2 		$1.8M Buy
+62,142
New +$1.85M ﹤0.01% 5136
2021
Q1 		– Sell
-26,757
Closed -$1.23M – 12492
2020
Q4 		$1.23M Sell
26,757
-411
-2% -$17.7K ﹤0.01% 6219
2020
Q3 		$1.06M Buy
+27,168
New +$1.04M ﹤0.01% 5984

Other funds holding IDNA

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CCA
Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return

Susquehanna International Group's IDNA Position: Q1 2026 in Review

Susquehanna International Group sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q1 2026, closing a stake of 12,655 shares — an estimated $331K sold.

Susquehanna International Group first reported a position in IDNA in Q3 2020 and held it in 14 quarters. The position peaked at $2.18M in Q4 2024. 60 funds tracked by Wall St. Rank hold IDNA as of Q1 2026.

  • Susquehanna International Group reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 12,655 iShares Genomics Immunology and Healthcare ETF shares in Q1 2026, an estimated $331K.
  • Susquehanna International Group first reported a position in iShares Genomics Immunology and Healthcare ETF in Q3 2020 and held it in 14 quarters.
  • Susquehanna International Group's iShares Genomics Immunology and Healthcare ETF position peaked at $2.18M in Q4 2024.
  • 60 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.